Because low plasma erythropoietin levels are present in anemia of prematurity, it has been theorized that enhancing erythropoiesis with recombinant erythropoietin (rhEPO) would reduce the need for ...

Recombinant human erythropoietin (rEpo) is neuroprotective in neonatal models of hypoxic-ischemic brain injury. However, the optimal rEpo dose, dosing interval, and number of doses for reducing ...

Routine administration of recombinant erythropoietin to patients on hemodialysis has greatly facilitated the management of chronic-kidney-disease-induced anemia. However, this glycoprotein hormone ...

It has been proposed that, in the face of such production requirements, EPO is either more efficient in the stimulation of erythropoiesis during fetal development or that other growth factors ...

Compared to placebo, high-dose recombinant human erythropoietin within 2 days of life does not improve neurodevelopmental outcomes for preterm infants.

Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant human erythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit ...

Availability of numerous biosimilars has rendered low-cost options for patients, therefore, increased adoption rates for EPO drugs particularly in developing regions, which boosts the market growth.

In a statement, the World Anti-Doping Agency said it would conduct a review of its EPO procedures. "While we have no reason to question the validity of the analytical method used for recombinant ...

Last month the AIU banned Kenyan pair Hosea Kimeli Kisorio and Ayub Kiptum for three years, for use of recombinant erythropoietin (EPO) and testosterone respectively. Meanwhile, the World Anti ...